| A machine learning algorithm based on multi-omics biomarkers for the detection of tumor microsatellite instability. KC Strickland, S Pabla, ZD Wallen, MK Nesline, HC Ko, RA Previs, ... Journal of Clinical Oncology 42 (16_suppl), 1554-1554, 2024 | | 2024 |
| Interaction between VEGF-A and immune checkpoint targets in triple-negative breast cancer and mechanisms of immune evasion and tumor progression. RJ Seager, S Pabla, S Gandhi, MF Senosain, H Parikh, E Van Roey, ... Journal of Clinical Oncology 42 (16_suppl), 1096-1096, 2024 | | 2024 |
| Screening for social determinants of health among patients with advanced and metastatic cancer undergoing comprehensive genomic profiling in underserved communities. MK Nesline, K Amoah, P DePietro, Z Bliss, ZD Wallen, S Naidu, KB Patel, ... Journal of Clinical Oncology 42 (16_suppl), e13545-e13545, 2024 | | 2024 |
| Evaluating tumor inflammation and PD-L1 expression in sequential biopsies of real-world primary and metastatic breast cancer. ZD Wallen, S Pabla, MK Nesline, S Gao, E Vanroey, P DePietro, ... Journal of Clinical Oncology 42 (16_suppl), e13035-e13035, 2024 | | 2024 |
| Comprehensive genomic and immune profiling of non-V600 BRAF-mutated melanomas: Implications for therapeutic strategies beyond BRAF/MEK inhibitors. MF Senosain, S Pabla, RJ Seager, E Van Roey, S Gao, H Parikh, ... Journal of Clinical Oncology 42 (16_suppl), e21544-e21544, 2024 | | 2024 |
| Novel HLA-Ilo/HLA-IIhi phenotype and immune evasion in triple-negative breast cancer. HC Ko, RJ Seager, S Gandhi, MF Senosain, H Parikh, E Van Roey, S Gao, ... Journal of Clinical Oncology 42 (16_suppl), 1095-1095, 2024 | | 2024 |
| Pervasive loss of antigen presentation in solid tumors driven by loss of HLA class I expression. S Pabla, HC Ko, MF Senosain, H Parikh, RJ Seager, E Van Roey, S Gao, ... Journal of Clinical Oncology 42 (16_suppl), e14654-e14654, 2024 | | 2024 |
| Multi-specimen comprehensive genomic profiling for diagnostic disambiguation in advanced and metastatic solid tumors. MK Nesline, ZD Wallen, KC Strickland, P Sathyan, EA Severson, ... Journal of Clinical Oncology 42 (16_suppl), e15166-e15166, 2024 | | 2024 |
| Analytical validation of the Labcorp Plasma Complete test to enable precision oncology through solid tumor liquid biopsy comprehensive genomic profiling. E Verner, KC Valkenburg, C Maddox, K Gerding, J Occean, JR White, ... Journal of Clinical Oncology 42 (16_suppl), 3063-3063, 2024 | | 2024 |
| Abstract PO5-06-09: Metastatic triple negative breast cancer has distinct tumor immune landscape R Seager, H Ko, S Pabla, MF Senosain, E Van Roey, S Gao, K Strickland, ... Cancer Research 84 (9_Supplement), PO5-06-09-PO5-06-09, 2024 | | 2024 |
| Abstract PO4-25-03: Comprehensive immune profiling reveals factors associated with neoadjuvant chemotherapy response in triple negative breast cancer R Seager, H Ko, S Pabla, MF Senosain, P Kalinski, E Van Roey, S Gao, ... Cancer Research 84 (9_Supplement), PO4-25-03-PO4-25-03, 2024 | | 2024 |
| Abstract PO4-14-11: Findings of clinically significant variants (Tier IA) with OmniSeq INSIGHT® in a breast cancer cohort of 987 patients H Ko, DP Dash, E Severson, K Strickland, Z Bliss, P DePietro, J Conroy, ... Cancer Research 84 (9_Supplement), PO4-14-11-PO4-14-11, 2024 | | 2024 |
| Immunologic Factors Associated with Differential Response to Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer RJ Seager, H Ko, S Pabla, MF Senosain, P Kalinski, E Van Roey, S Gao, ... Journal of Personalized Medicine 14 (5), 481, 2024 | | 2024 |
| Targetable genomic profiling of breast cancer brain metastases identifies alterations and genomic signatures relevant to immune-checkpoint and PARP inhibitors C Palmieri, A Giannoudis, E Sokol, T Bhogal, S Ramkissoon, E Razis, ... | | 2024 |
| Smoking-related Genomic Alterations Are Observed in Patients with Glioma and May Contribute to Shortened Survival (P4-5.017) J Landry, G Bognet, S Ahr, S Ramkissoon, M Chan, C Cramer, S Tatter, ... Neurology 102 (17_supplement_1), 6113, 2024 | | 2024 |
| Landscape of TIGIT and PD-L1 co-expression in solid tumors S Pabla, MF Senosain, RJ Seager, H Parikh, E Van Roey, S Gao, ... Cancer Research 84 (6_Supplement), 7526-7526, 2024 | | 2024 |
| Analytical performance of contrived samples for validation of liquid biopsy assays AE Harvey, CK Maddox, SO Dillon, OT Khawar, EL Verner, A Greer, ... Cancer Research 84 (6_Supplement), 5017-5017, 2024 | | 2024 |
| Validation of an automated, scalable comprehensive genomic profiling assay for hematologic malignancies G Hogg, T Liu, H Cao, A Shafi, A Shabaneh, J Williams, J Howitt, ... Cancer Research 84 (6_Supplement), 4628-4628, 2024 | | 2024 |
| Landscape of HIF-1α expression across 24,186 solid tumors using comprehensive immune profiling HI Parikh, S Pabla, MF Senosain, R Seager, E Vanroey, S Gao, ... Cancer Research 84 (6_Supplement), 379-379, 2024 | | 2024 |
| Pre-analytical characterization of cell-free DNA to enable liquid biopsy for solid tumors RJ Summersgill, JM Fox, JS Dickey, LT Cox, CD Palumbo, ... Cancer Research 84 (6_Supplement), 5020-5020, 2024 | | 2024 |
